Opportunities for Pan-Spectrum Drugs against Herpes
Predicting the Unpredictable
GPCR FlAsH-Walk Mapping: A Leap into the Future
A promising projects portfolio
As of today, CQDM has 34 outstanding research projects for a total of $ 31.8 million invested. These projects are carried out by a network of 400 researchers, including close to 60 graduate students, from 46 research institutions (25 public and 21 private) in Quebec, Canada and internationally. These projects cut across more than 70 mentors from CQDM’s pharmaceutical companies members.